Medical Properties Trust, Inc. (MPW)
NYSE: MPW · IEX Real-Time Price · USD
4.420
-0.420 (-8.68%)
At close: Apr 19, 2024, 4:00 PM
4.410
-0.010 (-0.23%)
After-hours: Apr 19, 2024, 7:59 PM EDT
Medical Properties Trust Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for MPW stock have an average target of 5.82, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 31.67% from the current stock price of 4.42.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for MPW stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 4 | 4 | 4 | 6 |
| Sell | 4 | 4 | 4 | 4 | 4 | 4 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Strong Sell → Hold Upgrades $2 → $5 | Strong Sell → Hold | Upgrades | $2 → $5 | +13.12% | Apr 17, 2024 |
| Colliers Securities | Colliers Securities | Hold Maintains $4.25 → $5 | Hold | Maintains | $4.25 → $5 | +13.12% | Apr 15, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $4 → $4.5 | Hold | Maintains | $4 → $4.5 | +1.81% | Apr 8, 2024 |
| Exane BNP Paribas | Exane BNP Paribas | Hold → Buy Upgrades $6 | Hold → Buy | Upgrades | $6 | +35.75% | Mar 1, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +13.12% | Feb 20, 2024 |
Financial Forecast
Revenue This Year
1.16B
from 871.80M
Increased by 33.17%
Revenue Next Year
1.16B
from 1.16B
Decreased by -0.43%
EPS This Year
0.42
from -0.93
EPS Next Year
0.53
from 0.42
Increased by 26.70%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.4B | 1.4B | 1.3B | 1.3B | 1.4B |
| Avg | 1.2B | 1.2B | 1.1B | 1.3B | 1.3B |
| Low | 950.6M | 938.1M | 1.0B | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 56.1% | 20.3% | 12.8% | 16.0% | 5.5% |
| Avg | 33.2% | -0.4% | -0.7% | 11.6% | 1.4% |
| Low | 9.0% | -19.2% | -12.3% | 8.3% | -1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.55 | 0.60 | 0.54 |
| Avg | 0.42 | 0.53 | 0.51 |
| Low | 0.21 | 0.43 | 0.48 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 43.8% | 1.6% |
| Avg | - | 26.7% | -4.2% |
| Low | - | 3.6% | -8.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.